Bristol-Myers Squibb

Large Scale Cell Culture Project - Phase 1

Project Overview

Arden’s extensive capacity and experience in the prefabrication of pharmaceutical process piping helped BMS achieve extraordinary schedule targets in the construction of this large-scale and complex life sciences facility.

Project Detail

In the fight against serious disease, biologics – or protein-derived therapies – are playing an increasingly prominent role. Pharmaceutical giant Bristol-Myers Squibb (BMS) is leading the advancement of this research application by
investing an estimated one billion dollars in the construction of a 1.5 million-square-foot biologics manufacturing plant in Devens, MA. The magnitude of
the BMS Large Scale Cell Culture (LSCC) project and the speed with which it was
completed is unprecedented.

Download Case Study (PDF)

Project Specifications

Contract Amount: $18,000,000

Total Project Value: $660,000,000

Construction Manager: Parsons/Skanska USA

Architect: Fluor

Mechanical Engineer: Parsons Group

Facility Type: Pharmaceutical

Facility Size: 400,000 SF

Schedule: March 2008-April 2008

Project Location: Devens, MA

Highlights / Achievements

100,000 Man Hours

Hyper-track Schedule

Pipe Fabrication and Installation Ahead of Evolving Design

Modular Construction Process

Intense Phasing and Coordination

Expansion of Fabrication Capabilities during Peak Production Periods

Building Information Modeling

LEED Certication Project

Value Delivered

Arden’s extensive capacity and experience in the prefabrication of pharmaceutical process piping helped BMS achieve extraordinary schedule targets in the construction of this large-scale and complex life sciences facility. Having invested 100,000 man hours within a dynamic hyper-track schedule, Arden utilized modular construction so that process and utility piping were fabricated into steel frames prior to installation.